← All trials
NCT01481259
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2010
- Primary completion
- Jan 1, 2013
- Completion date
- Jul 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Guangxi Medical UniversityLead sponsor
- Guangxi Medical UniversityOverall official - principal investigator
- Bureau of Science and Technology of Guangxi Province, ChinaStudy chair
- Guangxi Medical UniversityReponsible party - principal investigator
- Guangxi Medical UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.